WATCH THIS If Your CHOLESTEROL Is HIGH On KETO

The Metabolic-Atherosclerotic Paradox00:00:00

Dr. Hampton discusses the common conflict where patients achieve significant metabolic improvements like weight loss and lower A1C on ketogenic diets, only to see their LDL and ApoB levels rise, creating a debate between metabolic health and cardiovascular risk.

Understanding Particle Number vs. Particle Size00:02:49

Explains why LDL particle size is secondary to particle count. ApoB serves as a better proxy for the total number of atherogenic particles in the bloodstream, which is a critical factor in heart disease risk, regardless of how large or fluffy the LDL particles are.

Atherogenic Exposure and Risk Modeling00:04:40

Introduces the concept of atherosclerotic burden as a product of particle exposure over time, influenced by individual susceptibility factors like inflammation, blood pressure, and genetics.

The Role of Diet and Clinical Experiments00:07:55

Suggests a practical clinical experiment: maintaining metabolic gains while modifying fat intake—specifically reducing high-saturated fat sources like butter and heavy cream in favor of monounsaturated fats like olive oil and avocado to see if the ApoB particle count can be lowered.

Framework for Clinical Decision Making00:11:29

Provides a four-step framework: celebrate metabolic success, measure atherogenic markers (ApoB, Lp(a)), assess existing disease via CAC or CCTA if appropriate, and attempt to modulate ApoB without sacrificing metabolic health.